ABEV vs BUD vs TAP vs SAM

For growth investors, The Boston Beer Company, Inc.

(SAM) is the stronger pick with 3. 7% revenue growth year-over-year, versus -4. 2% for Molson Coors Beverage Company (TAP). Ambev S. A. (ABEV) offers the better valuation at 16. 5x trailing P/E (3. 1x forward), making it the more compelling value choice. Analysts rate Anheuser-Busch InBev SA/NV (BUD) a "Buy" — based on 45 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Ambev S.

A. (ABEV) is the cheapest at 16. 5x versus Anheuser-Busch InBev SA/NV at 27. 9x. On forward P/E, Ambev S. A. is actually cheaper at 3. 1x.

Over the past 5 years, Ambev S.

A. (ABEV) delivered a total return of +23. 3%, compared to -82. 6% for The Boston Beer Company, Inc. (SAM). Over 10 years, the gap is even starker: SAM returned +28. 4% versus TAP's -42. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Molson Coors Beverage Company (TAP) is the lower-risk stock at 0.

02β versus Ambev S. A. 's 0. 54β — meaning ABEV is approximately 2335% more volatile than TAP relative to the S&P 500. On balance sheet safety, The Boston Beer Company, Inc. (SAM) carries a lower debt/equity ratio of 4% versus 81% for Anheuser-Busch InBev SA/NV — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), The Boston Beer Company, Inc.

(SAM) is pulling ahead at 3. 7% versus -4. 2% for Molson Coors Beverage Company (TAP). On earnings-per-share growth, the picture is similar: The Boston Beer Company, Inc. grew EPS 95. 5% year-over-year, compared to -302. 8% for Molson Coors Beverage Company. Over a 3-year CAGR, ABEV leads at 3. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Ambev S.

A. (ABEV) is the more profitable company, earning 17. 6% net margin versus -19. 2% for Molson Coors Beverage Company — meaning it keeps 17. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BUD leads at 25. 9% versus -21. 0% for TAP. At the gross margin level — before operating expenses — BUD leads at 55. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Ambev S.

A. (ABEV) trades at 3. 1x forward P/E versus 20. 8x for The Boston Beer Company, Inc. — 17. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SAM: 21. 5% to $239. 78.

In this comparison, ABEV (8.

0% yield), TAP (4. 5% yield), BUD (1. 6% yield) pay a dividend. SAM does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Molson Coors Beverage Company (TAP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

02), 4. 5% yield). Both have compounded well over 10 years (TAP: -42. 1%, SAM: +28. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ABEV is a mid-cap deep-value stock; BUD is a mid-cap quality compounder stock; TAP is a small-cap income-oriented stock; SAM is a small-cap quality compounder stock. ABEV, BUD, TAP pay a dividend while SAM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.